KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Shares Outstanding (2016 - 2025)

Sarepta Therapeutics (SRPT) has 14 years of Shares Outstanding data on record, last reported at $105.4 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 10.39% year-over-year to $105.4 million; the TTM value through Sep 2025 reached $105.4 million, up 10.39%, while the annual FY2024 figure was $96900.0, 99.9% down from the prior year.
  • Shares Outstanding reached $105.4 million in Q3 2025 per SRPT's latest filing, up from $98.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $105.4 million in Q3 2025 and bottomed at $79830.0 in Q2 2021.
  • Average Shares Outstanding over 5 years is $54.3 million, with a median of $87.8 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: crashed 99.9% in 2021, then surged 109663.75% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $87127.0 in 2021, then skyrocketed by 100844.6% to $88.0 million in 2022, then rose by 6.57% to $93.7 million in 2023, then rose by 3.38% to $96.9 million in 2024, then grew by 8.79% to $105.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $105.4 million in Q3 2025, $98.4 million in Q2 2025, and $98.3 million in Q1 2025.